Cholesterol Testing Market is expected to grow at a CAGR of 6,92% through 2030F
Rising prevalence of cardiovascular diseases are expected
to drive the Global Cholesterol Testing Market growth in the forecast period,
2026-2030.
According to TechSci Research report, “Cholesterol Testing Market -
Industry Size, Share, Trends, Opportunity, and Forecast, 2020–2030F”, The
global cholesterol testing market stood at USD 12.36 billion in 2024 and is
anticipated to grow at a CAGR of 6.92% through 2030. The cholesterol testing
market is poised for significant growth, driven by ongoing innovation in the
pharmaceutical sector, particularly in the development and manufacturing of
cholesterol test kits. Factors such as the rising prevalence of cardiovascular
diseases, growing health awareness, and increasing demand for regular health
checkups are fueling market expansion. Emerging markets with improving
healthcare infrastructure and unmet medical needs offer substantial growth
opportunities. A decline in physical activity and unhealthy lifestyle habits
has heightened the need for frequent cholesterol monitoring.
The market is also benefiting from the rising popularity of
over-the-counter test kits and advancements in miniaturized electronics, which
enable the development of user-friendly self-testing devices. These innovations
are making cholesterol monitoring more accessible and convenient. However,
challenges such as limited access to diagnostic laboratories in remote areas
and stringent regulatory requirements may hinder growth. Despite these
barriers, the availability of skilled professionals in developing nations and
increased investments in healthcare infrastructure are expected to support
future expansion. The ongoing technological advancements and a growing focus on
preventive healthcare continue to create promising opportunities for the global
cholesterol testing market.
The Global Cholesterol Testing Market is segmented into product type, test
type, prescription mode, end user, regional distribution, and company.
Based on the type of product, The test kit segment is projected to be the fastest growing segment in the global cholesterol testing market. This surge in growth is largely fueled by increasing health awareness and the rising preference among consumers for convenient, at-home cholesterol monitoring solutions. Health-conscious individuals are increasingly adopting test kits to regularly track their cholesterol levels without the need for clinical visits. The widespread availability of affordable, user-friendly test kits from key market players has significantly expanded their reach. Additionally, heightened awareness about the dangers of high cholesterol—particularly its link to cardiovascular diseases—is encouraging more proactive health management. Lifestyle factors such as high-fat diets, smoking, alcohol consumption, and sedentary behavior continue to drive the need for regular cholesterol screening.
Based on region, Asia-Pacific is expected to exhibit
the highest growth rate during the forecast period. This growth can be
attributed to the presence of pharmaceutical companies in the region, as well
as the increasing purchasing power of populous countries such as China and
India. The rise in the geriatric population and the prevalence of
cardiovascular diseases such as diabetes are also driving market growth. The
Asia-Pacific region has a large population base, unmet medical needs, and
increasing disposable incomes. The region's growing medical tourism industry
and developing healthcare infrastructure make it a lucrative market for
cholesterol tests. Asia-Pacific offers profitable opportunities for key players
in the cholesterol test industry, registering the fastest growth rate during
the forecast period. This is due to the region's growing industrial
infrastructure, rising disposable incomes, and the well-established presence of
domestic companies. The rise in contract manufacturing organizations in the region
provides great opportunities for new entrants.
Major companies operating in Global Cholesterol Testing Market are:
· Abbott
Laboratories Inc.
· Beckman
Coulter Inc.
· Horiba
Ltd.
· Nova
Biomedical Corp.
· Roche
Holding Ag (F.Hoffmann-La Roche Ltd.)
· Randox
Laboratories Ltd.
· Siemens
Healthineers Gmbh
· Sekisui
Diagnostics LLC
· Sinocare
Inc.
· Thermo
Fisher Scientific Inc.
Customers can also request for 10% free customization
on this report.
“The global cholesterol testing market has experienced notable growth in recent
years, driven by increasing health awareness and the shift toward preventive
healthcare. Technological advancements have led to the development of accurate
and user-friendly testing methods, including point-of-care devices and at-home
cholesterol test kits. These innovations have improved accessibility and
convenience, encouraging regular monitoring. As individuals become more
proactive about managing their health, cholesterol tests are playing a critical
role in early risk detection and guiding timely lifestyle or medical
interventions. This growing demand continues to fuel market expansion across
both developed and emerging regions,” said Mr. Karan Chechi, Research Director OF TechSci Research, a research-based management consulting firm.
“Cholesterol Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Test Kits, Test Strips, Others), By Test Type (Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides/VLDL Cholesterol Test), By Prescription Mode (Over the Counter, Prescription Based), By End User (Hospitals & Clinics, Diagnostic Laboratories, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of
Global Cholesterol Testing Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global
Cholesterol Testing Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com